Perigon Wealth Management, LLC Biomarin Pharmaceutical Inc Transaction History

Perigon Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$75.51 - $84.79 $335,566 - $376,806	-4,444 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $276,127 - $335,099	3,695 Added 493.32%	4,444 $336,000
Q4 2020 Jan 28, 2021	BUY	$72.61 - $90.2 $54,384 - $67,559	749 New	749 $66,000
Q3 2019 Oct 25, 2019	SELL	$67.4 - $85.11 $182,586 - $230,562	-2,709 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$93.92 - $105.72 $42,451 - $47,785	-452 Reduced 14.3%	2,709 $263,000
Q2 2018 Aug 09, 2018	BUY	$76.01 - $99.03 $240,267 - $313,033	3,161 New	3,161 $298,000
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $175,168 - $206,336	-2,169 Closed	0 $0
Q3 2017 Dec 05, 2017	SELL	$80.6 - $94.95 $333,442 - $392,808	-4,137 Reduced 65.6%	2,169 $202,000
Q2 2017 Sep 12, 2017	BUY	N/A	6,306	6,306 $573,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.